○Thierry Bussière1, Paul Weinreb2, Fang Qian2, Joe Arndt2, Benjamin Smith2, Thomas o. Cameron2, Blake Pepinsky2, Chao Quan2, Krishna Praneeth Kilambi2 (1.Alzheimer & Dementia Research Unit, Biogen, USA, 2.Biologics Drug Discovery, Biogen, USA)
Session information
Symposium
[S-29] Alzheimer's disease up to date
Fri. May 25, 2018 1:45 PM - 3:45 PM Room 9 (Royton Sapporo / Regent Hall (2F))
Chair: Koji Abe(Department of Neurology, Okayama University, Japan), Atsushi Iwata(Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan)
Japan Society for Dementia Research
Recent Alzheimer's study has revealed basic pathogenesis of Alzheimer's disease. Longstanging synaptic dysfunction by Aß oligomers induces secondary infalmmation, vasculapthy and tauopathy. Here we provide most advances in this field by outstanding reserches and discuss prospective development for disease modifying therapies.
○Takeshi Kawarabayashi (Department of Neurology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Japan)
○Hiroki Sasaguri1,2, Misaki Sekiguchi1, Ryo Fujioka1, Kenichi Nagata1, Takaomi Saido1 (1.RIKEN Center for Brain Science, Japan, 2.Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Japan)
○Toru Yamashita, Yun Zhai, Yumiko Nakano, Jingwei Shang, Tian Feng, Ryuta Morihara, Yusuke Fukui, Yasuyuki Ohta, Nozomi Hishikawa, Koji Abe (Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan)
○Masato Hasegawa (Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Japan)